Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Elahere
Generic name : Mirvetuximab Soravtansine
Manufactured By : Abbvie
Indications : EPITHELIAL OVARIAN CA,FALLOPIAN CA,PRIMARY PERITONEAL CA
Medicine Description : Elahere is an antibody-drug conjugate targeting FRα-positive ovarian cancer. It binds to cancer cells, delivering a cytotoxic agent that induces cell death. Administered via IV infusion, it offers a targeted approach for platinum-resistant cases. Side effects include eye toxicity, fatigue, nausea, and low blood counts. Regular eye exams are required to monitor vision-related side effects.
Elahere (Mirvetuximab Soravtansine) is a prescription drug used to treat ovarian cancer, specifically for patients with folate receptor-alpha (FRα)-positive, platinum-resistant ovarian cancer.
Elahere is an antibody-drug conjugate (ADC) that targets FRα on cancer cells, delivering a potent chemotherapy agent directly to the tumor to inhibit its growth.
Elahere is prescribed for adult patients with FRα-positive ovarian, fallopian tube, or primary peritoneal cancer who have received prior treatments but their cancer has become resistant to platinum-based chemotherapy.
Elahere is given as an intravenous (IV) infusion by a healthcare professional, usually every three weeks.
Common side effects include nausea, fatigue, diarrhea, vision changes, dry eyes, and increased liver enzymes.
Yes, Elahere may cause eye problems (such as blurred vision and dry eyes), severe liver issues, or infusion-related reactions. Consult your doctor if serious symptoms occur.
Elahere is taken as long as it is effective and tolerated, or until the doctor advises stopping treatment.
It is best to avoid alcohol while taking Elahere, as it may increase the risk of liver toxicity and other side effects.
No, Elahere may harm an unborn baby. Women should use effective contraception during and after treatment as advised by their doctor.
Yes, Elahere may interact with certain medications. Inform your doctor about all medicines, including supplements and herbal products, before starting treatment.
Since Elahere is given as an IV infusion by a healthcare provider, consult your doctor if you miss an appointment.
Elahere is an IV infusion, so food intake does not affect its administration. However, maintaining a healthy diet can support overall well-being.
Regular eye exams are required during treatment. Use lubricating eye drops if advised, and avoid driving if experiencing vision problems.
Elahere is stored and prepared by healthcare professionals before administration. Patients do not need to store it at home.
Elahere is available through hospitals, oncology clinics, or specialty pharmacies. A doctor’s prescription is required for access. Pharma Five assists in its procurement.